Diabetes duration and the risk of dementia: a cohort study based on German health claims data

Abstract Objective Diabetes is a risk factor for dementia but little is known about the impact of diabetes duration on the risk of dementia. We investigated the effect of type 2 diabetes duration on the risk of dementia. Design Prospective cohort study using health claims data representative for the older German population. The data contain information about diagnoses and medical prescriptions from the in- and outpatient sector. Methods We performed piecewise exponential models with a linear and a quadratic term for time since first type 2 diabetes diagnosis to predict the dementia risk in a sample of 13,761 subjects (2,558 dementia cases) older than 65 years. We controlled for severity of diabetes using the Adopted Diabetes Complications Severity Index. Results We found a U-shaped dementia risk over time. After type 2 diabetes diagnosis the dementia risk decreased (26% after 1 year) and reached a minimum at 4.75 years, followed by an increase through the end of follow-up. The pattern was consistent over different treatment groups, with the strongest U-shape for insulin treatment and for those with diabetes complications at the time of diabetes diagnosis. Conclusions We identified a non-linear association of type 2 diabetes duration and the risk of dementia. Physicians should closely monitor cognitive function in diabetic patients beyond the first few years after diagnosis, because the later increase in dementia occurred in all treatment groups.

[1]  M. Kivimäki,et al.  Association Between Age at Diabetes Onset and Subsequent Risk of Dementia. , 2021, JAMA.

[2]  D. Mauricio,et al.  Latent Autoimmune Diabetes in Adults: A Review of Clinically Relevant Issues. , 2020, Advances in experimental medicine and biology.

[3]  R. Govender,et al.  Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends , 2019, Journal of epidemiology and global health.

[4]  L. Tan,et al.  Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies , 2019, Ageing Research Reviews.

[5]  K. Lange,et al.  Psychosoziales und Diabetes , 2019, Diabetologie und Stoffwechsel.

[6]  G. Doblhammer,et al.  Different treatment forms of type II diabetes and the risk of dementia in German health claims data , 2019, Acta Diabetologica.

[7]  D. Nation,et al.  Importance of Treatment Status in Links Between Type 2 Diabetes and Alzheimer’s Disease , 2019, Diabetes Care.

[8]  M. Beyer,et al.  Performance of the adapted Diabetes Complications Severity Index translated to ICD-10. , 2019, The American journal of managed care.

[9]  Tseng Chin-Hsiao Metformin and the Risk of Dementia in Type 2 Diabetes Patients , 2019, Aging and disease.

[10]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[11]  D. Hogan,et al.  Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis , 2018, BMJ Open Diabetes Research & Care.

[12]  Jared M. Campbell,et al.  Metformin Use Associated with Reduced Risk of Dementia in Patients with Diabetes: A Systematic Review and Meta-Analysis , 2018, Journal of Alzheimer's disease : JAD.

[13]  G. Biessels,et al.  Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications , 2018, Nature Reviews Endocrinology.

[14]  A. Sharrett,et al.  Severe hypoglycaemia, mild cognitive impairment, dementia and brain volumes in older adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) cohort study , 2018, Diabetologia.

[15]  Scott M. Hofer,et al.  When Does Cognitive Decline Begin? A Systematic Review of Change Point Studies on Accelerated Decline in Cognitive and Neurological Outcomes Preceding Mild Cognitive Impairment, Dementia, and Death , 2018, Psychology and aging.

[16]  S. Zoungas,et al.  Age, age at diagnosis and diabetes duration are all associated with vascular complications in type 2 diabetes. , 2017, Journal of diabetes and its complications.

[17]  J. Khoury,et al.  β-Cell Function Over Time in Adolescents With New Type 2 Diabetes and Obese Adolescents Without Diabetes. , 2017, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[18]  H. Schiöth,et al.  Intranasal insulin in Alzheimer’s disease: Food for thought , 2017, Neuropharmacology.

[19]  Jean B. Cormack,et al.  Metformin vs sulfonylurea use and risk of dementia in US veterans aged ≥65 years with diabetes , 2017, Neurology.

[20]  A. Puttanna,et al.  Management of diabetes and dementia , 2017 .

[21]  R. Weinstock,et al.  Management of Adults With Diabetes and Cognitive Problems , 2016, Diabetes Spectrum.

[22]  Robert Platt,et al.  Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses. , 2016, Journal of clinical epidemiology.

[23]  W. Polonsky,et al.  Poor medication adherence in type 2 diabetes: recognizing the scope of the problem and its key contributors , 2016, Patient preference and adherence.

[24]  M. Woodward,et al.  Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia , 2015, Diabetes Care.

[25]  P. Austin,et al.  Risk of Dementia in Seniors With Newly Diagnosed Diabetes: A Population-Based Study , 2015, Diabetes Care.

[26]  Pau-Chung Chen,et al.  Progress of Diabetic Severity and Risk of Dementia. , 2015, The Journal of clinical endocrinology and metabolism.

[27]  L. Kappelle,et al.  Cognitive function in patients with diabetes mellitus: guidance for daily care , 2015, The Lancet Neurology.

[28]  E. T. Tchetgen Tchetgen,et al.  Estimating the Cognitive Effects of Prevalent Diabetes, Recent Onset Diabetes, and the Duration of Diabetes among Older Adults , 2015, Dementia and Geriatric Cognitive Disorders.

[29]  M. Woodward,et al.  Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes , 2014, Diabetologia.

[30]  Diabetes Mellitus,et al.  Diabetes Mellitus and Dementia , 2014, Current Diabetes Reports.

[31]  M. Trenell,et al.  Abstracts of the 49th Annual Meeting of the EASD , 2013, Diabetologia.

[32]  K. Lange,et al.  Psychosoziales und Diabetes (Teil 1) , 2013, Diabetologie und Stoffwechsel.

[33]  J. Semmens,et al.  Earlier age of dementia onset and shorter survival times in dementia patients with diabetes. , 2013, American journal of epidemiology.

[34]  A. Bhansali,et al.  Diabetes mellitus and risk of dementia: A meta‐analysis of prospective observational studies , 2013, Journal of diabetes investigation.

[35]  J. Segal,et al.  Validating the adapted Diabetes Complications Severity Index in claims data. , 2012, The American journal of managed care.

[36]  Robert Koch-Institut Daten und Fakten: Ergebnisse der Studie "Gesundheit in Deutschland aktuell 2010" , 2012 .

[37]  D. Sobieraj,et al.  Dosing Frequency and Medication Adherence in Chronic Disease , 2012, Journal of managed care pharmacy : JMCP.

[38]  J. Cauley,et al.  Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia. , 2012, Archives of neurology.

[39]  S. Lovestone,et al.  Risk of developing dementia in people with diabetes and mild cognitive impairment , 2010, British Journal of Psychiatry.

[40]  T. Cukierman-Yaffe Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) Trial , 2009, Diabetes Care.

[41]  L. Fratiglioni,et al.  Mid- and Late-Life Diabetes in Relation to the Risk of Dementia , 2009, Diabetes.

[42]  V. Pankratz,et al.  Association of duration and severity of diabetes mellitus with mild cognitive impairment. , 2008, Archives of neurology.

[43]  Nancy L. Pedersen,et al.  O1-05-08: Mid- and late-life diabetes in relation to the risk of dementia: A population-based twin study , 2008, Alzheimer's & Dementia.

[44]  Geert Jan Biessels,et al.  Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. , 2008, European journal of pharmacology.

[45]  W. Katon,et al.  Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. , 2008, The American journal of managed care.

[46]  C. Jagger,et al.  Diabetes and cognitive impairment: a community-based study of elderly subjects. , 1995, Age and ageing.

[47]  R. Klein,et al.  Onset of NIDDM occurs at Least 4–7 yr Before Clinical Diagnosis , 1992, Diabetes Care.

[48]  M. Hernán,et al.  Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer , 2018, JAMA oncology.

[49]  S. Agrawal Role of self- Care in management of diabetes mellitus. , 2016, The Journal of the Association of Physicians of India.